{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:01:48Z","timestamp":1777453308914,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Science and Technology Project of Jilin Provincial Health Commission","award":["2016ZC020"],"award-info":[{"award-number":["2016ZC020"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Therapy"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug-resistant Mycobacterium tuberculosis strains have challenged efforts to combat tuberculosis (TB), a major global killer. C-reactive protein (CRP) shows promise as a biomarker for TB screening, particularly in HIV-positive cases, with demonstrated sensitivity and specificity in meta-analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a meta-analysis to assess the accuracy of CRP for screening HIV-associated PTB in outpatients, combining the sensitivities and specificities of diagnostic tests. PubMed, Web of Science, and SCOPUS were searched for articles that were published until April 2024. Quality assessment was done using the QUADAS-2 scale, and analysis was conducted using the random-effect model in STATA 17.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighteen studies, primarily from Africa (2013\u20132023), were analysed from an initial pool of 1186. These studies included 5625 HIV patients, 1248 of whom had PTB coinfection. Using a CRP threshold of 10\u00a0mg\/L, 17 studies (5109 patients) showed 84% sensitivity (95% CI: 72%\u201391%) and 67% specificity (95% CI: 52%\u201379%) with I\n                      <jats:sup>2<\/jats:sup>\n                      = 84.91%. At 8\u00a0mg\/L, nine studies (3631 patients) reported 77% sensitivity (95% CI: 65%\u201386%) and 81% specificity (95% CI: 69%\u201389%) with I\n                      <jats:sup>2<\/jats:sup>\n                      = 86.75%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study showed that CRP may aid in screening for PTB in PLHIV but requires clinical assessment and additional tests. Its high sensitivity can rule out PTB, but low specificity necessitates further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13596535251345870","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:11:23Z","timestamp":1748934683000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The diagnostic significance of the C-reactive protein (CRP) in HIV\/TB coinfection: A systematic review and meta-analysis"],"prefix":"10.1177","volume":"30","author":[{"given":"Ying","family":"Gao","sequence":"first","affiliation":[{"name":"Jilin Provincial Institute of Tuberculosis Prevention and Control (Affiliated Hospital)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Ji","sequence":"additional","affiliation":[{"name":"Yantai Qishan Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9515-6872","authenticated-orcid":false,"given":"Qiuyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Bishan Hospital of Chongqing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/651492"},{"key":"e_1_3_4_3_2","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. World Health Organization, 2024. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024"},{"key":"e_1_3_4_4_2","unstructured":"Organization WH. Global tuberculosis programme 2023. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data"},{"key":"e_1_3_4_5_2","unstructured":"Organization WH. Global tuberculosis report (2021). https:\/\/www.who.int\/publications\/i\/item\/9789240037021"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891201"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30488-7"},{"key":"e_1_3_4_8_2","unstructured":"Organization WH. Systematic screening for active tuberculosis: principles and recommendation 2013. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK294083\/"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133566"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(01)90328-1"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000085"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0811"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_4_14_2","volume-title":"A clinical prediction score including trial of antibiotics and C-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with HIV. Open forum infectious diseases","author":"Boyles TH","year":"2020","unstructured":"Boyles TH, Nduna M, Pitsi T, et al. (eds)A clinical prediction score including trial of antibiotics and C-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with HIV. Open forum infectious diseases. Oxford University Press US, 2020."},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2019.100107"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0519"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05916-z"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piac015"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061907"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115281"},{"key":"e_1_3_4_21_2","volume-title":"Plasma profiles of inflammatory markers associated with active tuberculosis in antiretroviral therapy-naive human immunodeficiency virus-positive individuals. Open Forum Infectious Diseases","author":"Olsson O","year":"2019","unstructured":"Olsson O, Bj\u00f6rkman P, Jansson M, et al. (eds) Plasma profiles of inflammatory markers associated with active tuberculosis in antiretroviral therapy-naive human immunodeficiency virus-positive individuals. Open Forum Infectious Diseases. Oxford University Press US, 2019."},{"issue":"1","key":"e_1_3_4_22_2","first-page":"481","article-title":"Accuracy of C-reactive protein and a differentiated white cell count in diagnosing tuberculosis","volume":"38","author":"Ruder G","year":"2023","unstructured":"Ruder G, Carter RM, Joubert G. Accuracy of C-reactive protein and a differentiated white cell count in diagnosing tuberculosis. S Afr J Infect Dis 2023; 38(1): 481.","journal-title":"S Afr J Infect Dis"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00113-4"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254002"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001902"},{"issue":"1","key":"e_1_3_4_26_2","first-page":"31","article-title":"Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults","volume":"10","author":"Wilson D","year":"2006","unstructured":"Wilson D, Nachega J, Morroni C, et al. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis 2006; 10(1): 31\u201338.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015248"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0347-6"},{"issue":"2","key":"e_1_3_4_29_2","first-page":"1","article-title":"An observational case-control study to determine human immunodeficiency virus and host factor influence on biomarker distribution and serodiagnostic potential in adult pulmonary tuberculosis","volume":"4","author":"Mohd HK","year":"2019","unstructured":"Mohd HK, Garcia ML, Anderson DA. An observational case-control study to determine human immunodeficiency virus and host factor influence on biomarker distribution and serodiagnostic potential in adult pulmonary tuberculosis. Tropical Medicine and Infectious Disease 2019; 4(2): 1\u201314. https:\/\/doi.org\/10.3390\/tropicalmed4020057","journal-title":"Tropical Medicine and Infectious Disease"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017871"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.2016.1168693"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040569"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144292"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy253"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001067"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318251ae0b"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0733"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000278"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0737"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3303-6"},{"key":"e_1_3_4_41_2","unstructured":"Organization WH. High priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting 2014. https:\/\/www.who.int\/publications\/i\/item\/WHO-HTM-TB-2014.18"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz015"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0078"},{"key":"e_1_3_4_44_2","unstructured":"Organization WH. The end TB strategy 2015. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/the-end-tb-strategy"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000391"}],"container-title":["Antiviral Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13596535251345870","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13596535251345870","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13596535251345870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:53:24Z","timestamp":1777380804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13596535251345870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/13596535251345870"],"URL":"https:\/\/doi.org\/10.1177\/13596535251345870","relation":{},"ISSN":["1359-6535","2040-2058"],"issn-type":[{"value":"1359-6535","type":"print"},{"value":"2040-2058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"article-number":"13596535251345870"}}